-
There is little disagreement about the merit of treating frank hypothyroidism. Because of conflicting data, much less consensus exists about whether subclinical hypothyroidism (ie, elevated TSH levels with normal T4) should be treated. Since thyroid disorders increase with age, a population of advanced years is an appropriate group in which to evaluate this issue further.
-
A new agent has received expedited FDA approval for the treatment of relapsing multiple sclerosis.
-
Atenolol is unsuitable as a first-line drug in hypertension.
-
Pharmacotherapy of hypertension has been much in the news in the last 2 months. Standard therapies such as atenolol have been challenged, while calcium channel antagonists may be making a comeback.
-
Most neoplastic lesions are not detected either by Hemoccult screening or by multitarget analysis of fecal DNA. Nevertheless, the fecal DNA analysis was significantly more efficient than Hemoccult testing.
-
Maintaining INRs (International normalized ratios) between 2 and 3 is safer than INRs below 2, as suggested by some guidelines.
-
Brown DJ. Extract of Pelargonium sidoides for treatment of acute bronchitis and tonsillopharyngitis. Altern Med Alert 2005;1(8):8-11.
-
Hardy ML. Magnesium and riboflavin for migraine: A review. Altern Med Alert 2005;8(1):3-8.
-
O'Mathuna DP. Low-fat diets and weight loss. Altern Med Alert 2005;8(1):1-3.
-
Strategies for cold and flu season: Stopping the spread of germs. Altern Med Alert 2005;8(suppl 1):S1-S2.